JORDAN GUERRA: Open Payments
NPI 1386207280 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 28 payments from 6 companies in 2025. Trend: 2023 $114 · 2024 $623 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| Amgen Inc. | 14 | $141 |
| Abbott Laboratories | 4 | $86 |
| Dexcom, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: FARXIGA, Repatha, FREESTYLE LIBRE 3, OTEZLA, Dexcom G6 Transmitter, AIRSUPRA, VRAYLAR, GEMTESA.
Industry payments across TX — which companies pay providers there.
